About this item
Product details
Diampa LXR is a comprehensive, triple-combination oral medication designed for the management of type 2 diabetes in adults. It combines three anti-diabetic agents with complementary mechanisms: Empagliflozin (an SGLT2 inhibitor) helps remove excess sugar through urine, Linagliptin (a DPP-4 inhibitor) increases insulin release and decreases sugar production, and Metformin (a biguanide) reduces liver glucose output and improves insulin sensitivity. This powerful combination is used when dual therapy fails to achieve adequate blood sugar control, offering a simplified and effective treatment regimen. Triple-Action Sugar Control: Targets blood glucose through three distinct pathways for enhanced glycemic management. Cardiovascular & Renal Benefits: Empagliflozin component offers proven heart and kidney protection benefits in patients with type 2 diabetes. Composition Each film-coated tablet contains: Empagliflozin: 10 mg Linagliptin: 5 mg Metformin HCI USP: 1000 mg (as extended release) Directions for Use As directed by the physician.
- Medicines
- 14 Tablets
- 1 variant
- Protected Dastak checkout
Know before you buy
Specifications
- Department
- Health
- Subcategory
- Medicines
- Brand
- Getz Pharma
- SKU
- 08964003891619
- Variant
- 14 Tablets
- Tags
- Empagliflozin, Linagliptin, Medicine, Metformin
- Condition
- New
Customer feedback
Ratings & reviews
For help with a purchase, open your orders or contact Dastak support.
